NCT04109339 is a NA clinical trial of Oxytocin in Oxytocin, sponsored by Yangzhou University.

Who is sponsoring NCT04109339?

NCT04109339 is sponsored by Yangzhou University.

What drugs are being tested in NCT04109339?

Interventions in NCT04109339: Oxytocin.

What condition does NCT04109339 study?

NCT04109339 studies Oxytocin, Hemodynamic Monitoring, Laparoscopic Surgery.

Is NCT04109339 still recruiting?

NCT04109339 is currently status unknown. Last updated 30 September 2019.

Last reviewed 2019-09-30 · How we verify

NCT04109339

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Effects of Oxytocin on Hemodynamics in Patients Undergoing Laparoscopic Myomectomy

Status unknown NA Last updated 30 September 2019

What this trial tests

NA trial testing Oxytocin in Oxytocin in 80 participants. Status unknown.

Timeline

1 May 2019

Primary endpoint
31 December 2019

1 October 2020

Quick facts

Lead sponsor	Yangzhou University
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	quadruple
Primary purpose	prevention
Enrollment	80
Start date	1 May 2019
Primary completion	31 December 2019
Estimated completion	1 October 2020
Sites	1 location across China

Drugs / interventions tested

Oxytocin (OXYTOCIN) — full drug profile →

Conditions studied

Oxytocin — all drugs for Oxytocin →
Hemodynamic Monitoring — all drugs for Hemodynamic Monitoring →
Laparoscopic Surgery — all drugs for Laparoscopic Surgery →

Sponsor

Yangzhou University

Who can join

Adults 18 to 65, female only, with Oxytocin or Hemodynamic Monitoring. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This project will study the effect of oxytocin on hemodynamics in patients undergoing laparoscopic myomectomy, and how to prevent and manage such hemodynamic changes effectively.It provides a reference for the rational use of oxytocin in clinical practice, which can not only effectively contract the uterus and reduce bleeding, but also reduce the influence on hemodynamics.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Oxytocin

Trials testing the same drug.

NCT07401524 — Carbetocin Uterotonic Treatment in Twin Pregnancies for Prevention of Postpartum Hemorrhage · Phase 4 · not yet recruiting
NCT07188207 — Rectal Misoprostol for Reducing Blood Loss in Elective Cesarean Section · NA · not yet recruiting
NCT06968481 — Sublingual Oxytocin for the Prevention of Post-partum Hemorrhage · Phase 2 · not yet recruiting
NCT07265180 — Oxytocin-Augmented Group Psychotherapy for Patients With Schizophrenia - an Oxytocin-dose Comparison · NA · recruiting
NCT07119398 — Oxytocin/Foley vs. Oxytocin for Induction in Patients With PPROM · Phase 4 · recruiting

Other recruiting trials for Oxytocin

Currently open trials in the same condition.

NCT07351799 — Mindfulness and Meditation Based Lactation Education on Maternal Breastmilk in the Neonatal ICU · NA · recruiting
NCT04551482 — Oxytocin for Weight Loss in Adolescents · Phase 2 · recruiting

Other Yangzhou University trials

Trials by the same sponsor.

NCT06517069 — Effect of TEAS Combined With Oxycodone on Postoperative Visceral Pain in Gynecologic Laparoscopic Patients · NA · recruiting
NCT05936918 — Application of Transcutaneous Electrical Acupoint Stimulation in Laparoscopic Cholecystectomy · NA · unknown
NCT05909696 — Median Effective Dose of Rocuronium for the Prevention of Myofibrillation Caused by the Injection of Succinylcholine · NA · completed
NCT05932485 — Effect of Stellate Ganglion Block on New Atrial Fibrillation After Coronary Artery Bypass Grafting · NA · completed
NCT06456710 — Effect of a Psychological Intervention on Stigma: a Randomized Controlled Study · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04109339 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Yangzhou University
Last refreshed: 30 September 2019

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04109339.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing